|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.105 USD | -.--% |
|
-.--% | -.--% |
Acro Biomedical Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 4 million compared to USD 3.93 million a year ago. Basic loss per share from continuing operations was USD 0.07 compared to USD 0.07 a year ago.
Diluted loss per share from continuing operations was USD 0.07 compared to USD 0.07 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 6.3M | |
| +11.32% | 7.78B | |
| +1.64% | 7.38B | |
| +10.50% | 6.52B | |
| -6.69% | 3.67B | |
| -13.51% | 3.44B | |
| -10.10% | 1.17B | |
| +8.34% | 934M | |
| -41.81% | 879M | |
| -19.81% | 836M |
ACRO BIOMEDICAL CO., LTD. 
